Exxel Pharma is eyeing a listing on the NYSE American to fund human trials for a drug class that has previously struggled to ...

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

In a stock market currently obsessed with interest rate cuts and the artificial intelligence (AI) boom, it is easy to overlook the biotechnology sector. However, for investors willing to look beyond ...

Biotech stock Anaptysbio cleared a trendline entry near 50 on Monday. Shares are also in a base with a buy point of 52.47.

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...

The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.

Legend Biotech (LEGN) has drawn investor attention after a sharp share price pullback, with the stock down about 20% over the past month and roughly 46% over the past 3 months. See our latest analysis ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

FAR Biotech, a computational drug discovery company, has officially relocated to Wisconsin. The move marks a significant milestone for the company, which is collaborating with the University ...